Biocon Breaks Ground In Latin America Through Agreement In Brazil
Indian Firm Expands Partnership With Local Player Libbs
Having together achieved success with biosimilar trastuzumab in Brazil, Biocon and local player Libbs Farmaceutica have reached an agreement to offer the Indian firm’s generic formulations in the market.
